Loading clinical trials...
Loading clinical trials...
Randomized Phase II Trial of Concurrent Chemoradiotherapy +/- Metformin HCL in Locally Advanced NSCLC
Conditions
Interventions
Radiation Therapy
Carboplatin
+2 more
Locations
224
United States
Lewis and Faye Manderson Cancer Center
Tuscaloosa, Alabama, United States
Banner University Medical Center - Tucson
Tucson, Arizona, United States
Sutter Cancer Centers Radiation Oncology Services-Auburn
Auburn, California, United States
Sutter Cancer Centers Radiation Oncology Services-Cameron Park
Cameron Park, California, United States
Eden Hospital Medical Center
Castro Valley, California, United States
UC San Diego Moores Cancer Center
La Jolla, California, United States
Start Date
August 1, 2014
Primary Completion Date
April 16, 2019
Completion Date
September 4, 2025
Last Updated
October 9, 2025
NCT03845296
NCT00946712
Lead Sponsor
NRG Oncology
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions